Profile
Kirk Bertelsen currently works at Viridian Therapeutics, Inc., as Senior VP & Head-Research from 2024.
Dr. Bertelsen also formerly worked at Magenta Therapeutics, Inc., as Head-Clinical Pharmacology.
Dr. Bertelsen received his undergraduate degree from the University of Oregon and doctorate degree from Sackler School of Graduate Biomedical Sciences.
Kirk Bertelsen active positions
| Companies | Position | Start |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2023 |
Former positions of Kirk Bertelsen
| Companies | Position | End |
|---|---|---|
| MAGENTA THERAPEUTICS | Corporate Officer/Principal | - |
Training of Kirk Bertelsen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Oregon
University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sackler School of Graduate Biomedical Sciences
Sackler School of Graduate Biomedical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
- Stock Market
- Insiders
- Kirk Bertelsen
















